Tuesday, November 03, 2026

Manipal Hospitals Promotes BE FAST Approach To Stroke Detection

 Manipal Hospitals EM Bypass and Mukundapur organised a stroke awareness programme in Kolkata on 29 October, 2026, to mark World Stroke Day, highlighting the importance of early detection, prevention and timely medical intervention. The initiative brought together neurological specialists to educate people about stroke symptoms, associated risk factors and the need for immediate medical attention to minimise long-term disability.

The programme featured Dr. Jayanta Roy, Director and Head of Neurology at Manipal Hospitals Mukundapur; Dr. Amlan Mandal, Consultant and Head of Neurology at Manipal Hospitals EM Bypass; Dr. Sukalyan Purkayastha, Director and Senior Consultant, Neurointervention and Endovascular Surgery, Manipal Hospitals East Region; and Dr. Nirmalya Roy, Consultant, Neuroradiology, Manipal Hospitals EM Bypass.

Recognising Early Warning Signs
A key focus of the programme was the BE FAST approach, an acronym for identifying common stroke symptoms. It stands for Balance, Eyes, Face, Arms, Speech and Time. Warning signs include sudden loss of balance, blurred or double vision, facial drooping, weakness in one arm and difficulty speaking. The final step emphasises seeking emergency medical assistance immediately and noting when symptoms began.

The specialists also highlighted transient ischaemic attacks (TIAs), commonly known as warning strokes. These episodes can cause symptoms similar to those of a stroke, including weakness, speech difficulties and visual disturbances, which may disappear within a short period. However, symptom resolution does not eliminate the underlying risk. A TIA requires urgent medical evaluation because it can indicate an increased risk of a subsequent stroke.

Dr. Jayanta Roy said stroke is a medical emergency in which every minute matters, adding that early recognition and immediate medical assessment can help limit brain damage and improve recovery prospects. Dr. Amlan Mandal highlighted that stroke can affect younger individuals as well as older adults, making awareness and regular health assessments important across age groups. Dr. Sukalyan Purkayastha emphasised managing risk factors such as hypertension, diabetes and elevated cholesterol. Smoking, physical inactivity, obesity and sleep apnoea were also identified as contributing factors.

Dr. Nirmalya Roy stressed the importance of prompt treatment, citing the principle that 'time is brain'. He noted that approximately 20 million brain cells may be lost every minute during a major ischaemic stroke. The programme reinforced the importance of regular health check-ups, balanced nutrition, physical activity and appropriate medical care to reduce stroke risks and improve recovery outcomes.

 

 

This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   

 

Labels: , , , , , , , , , ,

Long COVID Risk Higher with Autoimmune Rheumatic Diseases

Key Summary:

  • A retrospective cohort study matched patients with AIRD to controls after SARS-CoV-2 infection.
  • Long COVID occurred in 2.8% with AIRD versus 1.5% without (adjusted hazard ratio: 1.56; 95% CI: 1.45–1.67).
  • The authors called for identification of risk factors to minimise the long-term effects of Long COVID.

LONG COVID has been found to be more common among people with autoimmune rheumatic diseases (AIRD) than among matched controls, according to a large US analysis, which has also linked specific treatments and clinical factors to a higher risk of developing the condition.

Long COVID in Rheumatic Disease

Long COVID has remained a significant concern since the pandemic, and patients with AIRD, including those receiving immunomodulatory therapy, have become a group of particular interest. Before this study, little was known about the prevalence of Long COVID in people with autoimmune rheumatic diseases or about the factors associated with it.

How Was the Cohort Assembled?

Researchers conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C). Adults with a first documented SARS-CoV-2 infection (September 2021–December 2023) were included, with follow-up through December 2024.

Long COVID was defined using the International Classification of Diseases, 10th Revision, Clinical Modification code U09.9, or a Long COVID clinic visit occurring 28–365 days after first infection.

Patients with AIRD were compared with matched controls without AIRD using 1:1 nearest-neighbour propensity score matching on age, with exact matching on sex, race/ethnicity, SARS-CoV-2 variant-dominant period and data-contributing organisation.

Which Patients Faced Higher Risk?

In the matched cohort of 187,106 patients, Long COVID occurred in 2.8% of patients with AIRD and 1.5% of patients without AIRD.

In multivariable analyses, AIRD was associated with an increased risk of Long COVID compared with non-AIRD status (adjusted hazard ratio: 1.56; 95% CI: 1.45–1.67).

Among patients with AIRD, higher acute COVID-19 severity, pulmonary disease, obesity, and exposure to rituximab or glucocorticoids were associated with an increased risk of Long COVID.

Sjögren’s syndrome was also associated with a higher risk of Long COVID.

What Should Clinicians Consider Next?

The higher risk of Long COVID among patients with autoimmune rheumatic diseases has highlighted the need to identify potential risk factors in this population to minimise long-term effects. Clinicians should remain alert to Long COVID in patients with higher-risk features, while further research is needed to confirm these associations.

 

This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   

 

Labels: , , , ,